Roche gains platelet function test offering with Verum acquisition
This article was originally published in Clinica
Executive Summary
Roche is expanding its coagulation testing portfolio by agreeing to buy German firm Verum Diagnostica in a deal worth up to €13m ($17.4m). The Swiss company will pay €11m upfront, plus up to €2m in milestone payments, with the transaction expected to close in January 2012.